Compounds > 1-phenyl-2-decanoylamino-3-morpholino-1-propanol

1-phenyl-2-decanoylamino-3-morpholino-1-propanol and imatinib mesylate

1-phenyl-2-decanoylamino-3-morpholino-1-propanol has been researched along with imatinib mesylate in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baran, Y; Bielawski, J; Gunduz, U; Ogretmen, B1

Other Studies

1 other study(ies) available for 1-phenyl-2-decanoylamino-3-morpholino-1-propanol and imatinib mesylate

ArticleYear
Targeting glucosylceramide synthase sensitizes imatinib-resistant chronic myeloid leukemia cells via endogenous ceramide accumulation.
    Journal of cancer research and clinical oncology, 2011, Volume: 137, Issue:10

    Topics: Antineoplastic Agents; Apoptosis; Benzamides; Cell Cycle; Ceramides; Drug Resistance, Neoplasm; Glucosyltransferases; Humans; Imatinib Mesylate; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Morpholines; Piperazines; Pyrimidines

2011